Gut Bacteria and Chemicals May Offer Early Dementia Clues, Study Suggests
Researchers found that specific biomarkers in digestive samples could help identify mild cognitive impairment and predict the rate of decline.
Bacteria and chemicals found in the digestive system could serve as early indicators of dementia, according to a new study. Researchers suggest that these biomarkers in the gut may also predict how rapidly an individual's memory and thinking abilities will worsen.
Professor Paul Morgan of Cardiff University, who led the research, stated, "This study leads us to conclude that the gut could offer a window into what's happening in the brain at the earliest stages of cognitive decline." The findings were published in the journal MedComm.
The study involved analyzing fecal samples from 35 older adults, many of whom were couples where one partner had mild cognitive impairment (MCI) and the other did not. Using artificial intelligence (AI), the researchers aimed to determine if these samples could help diagnose MCI and forecast its progression.
The analysis revealed distinct differences in the gut bacterial composition between individuals with MCI and those without. Specifically, people with MCI showed significantly elevated levels of the bacteria Izemoplasmatales spp. and the gut chemical proline. Conversely, they had decreased levels of Ruminococcus spp. and Lachnospira spp. bacteria, along with lower levels of the chemical fumaric acid. These bacterial groups have been previously associated with brain health.
These specific bacterial markers were also tested on an independent group from a prior study, where they successfully distinguished individuals with MCI from healthy participants.
Furthermore, the researchers tracked individuals with MCI for one year. They observed that those with higher initial levels of Bilophila spp. bacteria and the chemicals arginine, aspartic acid, and hypoxanthine, alongside lower levels of Coprococcus spp., experienced a more rapid decline in memory and thinking skills.
Dr. You Zhou, a co-author from Cardiff University, highlighted the significance of these findings, noting that MCI affects about one in four older adults globally, and there is currently no simple method to identify those at risk of rapid decline. "We found that a combination of gut bacteria and chemicals could distinguish people with mild cognitive impairment from healthy individuals with high accuracy, and certain gut chemicals were strongly linked to faster decline over the following year," Dr. Zhou said. She added that while this was a small study requiring confirmation in larger cohorts, it points towards the potential for simple, non-invasive tests to aid in earlier diagnosis.
Professor Julian Marchesi from Imperial College London, another co-author, emphasized the growing recognition of the gut-brain connection. "Gut bacteria and chemicals are increasingly recognised as an important link between the gut and the brain," Professor Marchesi explained. "By looking at both together, we get a much fuller picture of what's changing in people with mild cognitive impairment." Future research aims to identify the most critical microbes and chemicals involved.
The research team noted that further studies are necessary across more diverse populations to explore the influence of factors such as diet, lifestyle, ethnicity, environment, and genetic predisposition.